India to Latvia: Velpatasvir Export Trade Route

The India to Latvia Velpatasvir corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $3.7M USD. The route is dominated by EURO LIFECARE PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's velpatasvir manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $736.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 29.0%, placing it at rank #11 among India's top velpatasvir export destinations globally.

On the import side, key buyers of Indian velpatasvir in Latvia include SIA "MAGNIPHARMA",, SIA MAGNIPHARMA ELIZABETES IELA, SIA MAGNIPHARMA. SIA "MAGNIPHARMA", is the single largest importer with 3 shipments valued at $1.7M USD.

India's velpatasvir exports to Latvia are driven primarily by a handful of large-scale manufacturers. EURO LIFECARE PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Latvia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EURO LIFECARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $736.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as velpanat film-coated tablets,400 mg,28 tablets in a bottle,1 bottle in a cardboared box sofosbuvir and velpatasvir 400m and velpanat (24 nos foc)(ws sofosbuvir 300mg and ws velpatasvir 150mg), suggesting that buyers in Latvia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SIA "MAGNIPHARMA", is the largest importer with 3 shipments worth $1.7M USD — representing 45% of all velpatasvir imports from India on this route.